These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 29107789)

  • 21. Solithromycin rejection chills antibiotic sector.
    Owens B
    Nat Biotechnol; 2017 Mar; 35(3):187-188. PubMed ID: 28267725
    [No Abstract]   [Full Text] [Related]  

  • 22. Development of an Adult Physiologically Based Pharmacokinetic Model of Solithromycin in Plasma and Epithelial Lining Fluid.
    Salerno SN; Edginton A; Cohen-Wolkowiez M; Hornik CP; Watt KM; Jamieson BD; Gonzalez D
    CPT Pharmacometrics Syst Pharmacol; 2017 Dec; 6(12):814-822. PubMed ID: 29068158
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antimicrobial activity of solithromycin against serotyped macrolide-resistant Streptococcus pneumoniae isolates collected from U.S. medical centers in 2012.
    Farrell DJ; Mendes RE; Jones RN
    Antimicrob Agents Chemother; 2015 Apr; 59(4):2432-4. PubMed ID: 25605359
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nature nurtures the design of new semi-synthetic macrolide antibiotics.
    Fernandes P; Martens E; Pereira D
    J Antibiot (Tokyo); 2017 May; 70(5):527-533. PubMed ID: 27899792
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Renaissance of antibiotics against difficult infections: Focus on oritavancin and new ketolides and quinolones.
    Van Bambeke F
    Ann Med; 2014 Nov; 46(7):512-29. PubMed ID: 25058176
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The order of administration of macrolides and beta-lactams may impact the outcomes of hospitalized patients with community-acquired pneumonia: results from the community-acquired pneumonia organization.
    Peyrani P; Wiemken TL; Metersky ML; Arnold FW; Mattingly WA; Feldman C; Cavallazzi R; Fernandez-Botran R; Bordon J; Ramirez JA
    Infect Dis (Lond); 2018 Jan; 50(1):13-20. PubMed ID: 28699429
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Contradiction between in vitro and clinical outcome: intravenous followed by oral azithromycin therapy demonstrated clinical efficacy in macrolide-resistant pneumococcal pneumonia.
    Kohno S; Tateda K; Kadota J; Fujita J; Niki Y; Watanabe A; Nagashima M
    J Infect Chemother; 2014 Mar; 20(3):199-207. PubMed ID: 24477328
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative efficacy and safety analysis of CSE-1034: An open labeled phase III study in community acquired pneumonia.
    Chaudhary M; Ayub SG; Mir MA;
    J Infect Public Health; 2018; 11(5):691-697. PubMed ID: 29803638
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Formulation development of SYN-004 (ribaxamase) oral solid dosage form, a β-lactamase to prevent intravenous antibiotic-associated dysbiosis of the colon.
    Bristol A; Hubert S; Hofmann F; Baer H
    Int J Pharm; 2017 Dec; 534(1-2):25-34. PubMed ID: 28986322
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Type III Secretion-Dependent Sensitivity of Escherichia coli O157 to Specific Ketolides.
    Fernandez-Brando RJ; Yamaguchi N; Tahoun A; McAteer SP; Gillespie T; Wang D; Argyle SA; Palermo MS; Gally DL
    Antimicrob Agents Chemother; 2016 Jan; 60(1):459-70. PubMed ID: 26525795
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Solithromycin to treat community-acquired pneumonia?
    Mushtaq A
    Lancet Respir Med; 2015 Jun; 3(6):429. PubMed ID: 25963714
    [No Abstract]   [Full Text] [Related]  

  • 32. Update on the combination effect of macrolide antibiotics in community-acquired pneumonia.
    Emmet O'Brien M; Restrepo MI; Martin-Loeches I
    Respir Investig; 2015 Sep; 53(5):201-9. PubMed ID: 26344609
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro activity of solithromycin and its metabolites, CEM-214 and N-acetyl-CEM-101, against 100 clinical Ureaplasma spp. isolates compared with azithromycin.
    Furfaro LL; Spiller OB; Keelan JA; Payne MS
    Int J Antimicrob Agents; 2015 Sep; 46(3):319-24. PubMed ID: 26141231
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Macrolides in community-acquired pneumonia: does the bell toll for thee?
    Granowitz EV; Brown RB
    Chest; 2005 Sep; 128(3):1089-93. PubMed ID: 16162689
    [No Abstract]   [Full Text] [Related]  

  • 35. In Vitro Activity of Solithromycin against Bordetella pertussis, an Emerging Respiratory Pathogen.
    Hardy DJ; Vicino D; Fernandes P
    Antimicrob Agents Chemother; 2016 Dec; 60(12):7043-7045. PubMed ID: 27620481
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The wobbly status of ketolides: where do we stand?
    Georgopapadakou NH
    Expert Opin Investig Drugs; 2014 Oct; 23(10):1313-9. PubMed ID: 25154307
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical and bacteriological efficacy and safety of 5 and 7 day regimens of telithromycin once daily compared with a 10 day regimen of clarithromycin twice daily in patients with mild to moderate community-acquired pneumonia.
    Tellier G; Niederman MS; Nusrat R; Patel M; Lavin B
    J Antimicrob Chemother; 2004 Aug; 54(2):515-23. PubMed ID: 15269191
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Trans-placental passage and anti-inflammatory effects of solithromycin in the human placenta.
    Keelan JA; Pugazhenthi K
    Placenta; 2014 Dec; 35(12):1043-8. PubMed ID: 25280973
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A randomized controlled clinical trial of levofloxacin 750 mg versus 500 mg intravenous infusion in the treatment of community-acquired pneumonia.
    Zhao X; Wu JF; Xiu QY; Wang C; Zhang DP; Huang JA; Xie CM; Sun SH; Lv XJ; Si B; Xiao ZK; Zhang YY
    Diagn Microbiol Infect Dis; 2014 Oct; 80(2):141-7. PubMed ID: 25130297
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of dry granulation on compactibility and capping tendency of macrolide antibiotic formulation.
    Bozic DZ; Dreu R; Vrecer F
    Int J Pharm; 2008 Jun; 357(1-2):44-54. PubMed ID: 18308490
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.